4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001209191-21-049114
Chief Medical Officer sold 15,000 shares at $45.00 ($675,000)
- Chief Medical Officer acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Crystal Adam Chief Medical Officer | 2021-07-29 | Option exercise | +15,000 | $4.98 | $74,700 | 15,000 | D |
| Crystal Adam Chief Medical Officer | 2021-07-29 | Sale | −15,000 | $45.00 | $675,000 | 0 | D |
| Derivatives | |||||||
| Crystal Adam Chief Medical Officer | 2021-07-29 | Option exercise · Stock Option (Right to Buy) | −15,000 | 183,108 | D | ||
| Open-market sales · 15,000 sh · avg $45.00 · $675,000 | |||||||
Loading xslF345X03/doc4.xml…